Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial

Authors: Steven R. Steinhubl, MD, Jill Waalen, MD, Alison M. Edwards, MStat, Lauren M. Ariniello, BS, Rajesh R. Mehta, RPh, Gail S. Ebner, BS, Chureen Carter, PharmD, Katie Baca-Motes, MBA, Elise Felicione, MPH, Troy Sarich, PhD, Eric J. Topol, MD.

Summary:

Randomized clinical trial comparing home based ECG patch monitoring (Zio XT) to delayed monitoring after 4 months.

Key Findings:

Immediate monitoring using a self-applied ECG patch compared with delaying ECG monitoring for 4 months, led to a significantly higher rate of AF diagnosis at 4 months (3.9% vs 0.9%).

Immediate monitoring cohort saw increased initiation of anticoagulants, outpatient cardiology visits, and primary care visits.

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.